AU701247B2 - Vaccine and method for treatment of chlamydial infections - Google Patents
Vaccine and method for treatment of chlamydial infections Download PDFInfo
- Publication number
- AU701247B2 AU701247B2 AU11297/95A AU1129795A AU701247B2 AU 701247 B2 AU701247 B2 AU 701247B2 AU 11297/95 A AU11297/95 A AU 11297/95A AU 1129795 A AU1129795 A AU 1129795A AU 701247 B2 AU701247 B2 AU 701247B2
- Authority
- AU
- Australia
- Prior art keywords
- momp
- strains
- chlamydia psittaci
- ebs
- sds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14763693A | 1993-11-03 | 1993-11-03 | |
US08/147636 | 1993-11-03 | ||
PCT/US1994/012626 WO1995012411A1 (en) | 1993-11-03 | 1994-11-02 | Vaccine and method for treatment of chlamydial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1129795A AU1129795A (en) | 1995-05-23 |
AU701247B2 true AU701247B2 (en) | 1999-01-21 |
Family
ID=22522314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11297/95A Ceased AU701247B2 (en) | 1993-11-03 | 1994-11-02 | Vaccine and method for treatment of chlamydial infections |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0726775A4 (zh) |
CN (1) | CN1134112A (zh) |
AU (1) | AU701247B2 (zh) |
BR (1) | BR9407986A (zh) |
CA (1) | CA2175081A1 (zh) |
NZ (1) | NZ276874A (zh) |
WO (1) | WO1995012411A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2184132C (en) * | 1995-09-21 | 2011-03-15 | Kristina J. Hennessy | An adjuvanted vaccine which is substantially free of non-host albumin |
US5972350A (en) * | 1996-05-06 | 1999-10-26 | Bayer Corporation | Feline vaccines containing Chlamydia psittaci and method for making the same |
US7459524B1 (en) | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
EP1108033A2 (en) * | 1998-07-27 | 2001-06-20 | Aventis Pasteur Limited | $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
WO2000034498A1 (en) * | 1998-12-04 | 2000-06-15 | University Of Manitoba | Two-step immunization procedure against chlamydia infection |
CA2395499C (en) | 1999-12-22 | 2011-10-25 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
AU2138501A (en) * | 1999-12-22 | 2001-07-03 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
AU2138601A (en) * | 1999-12-22 | 2001-07-03 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
ES2386386T3 (es) * | 2001-12-12 | 2012-08-20 | Novartis Vaccines And Diagnostics S.R.L. | Inmunización contra Chlamydia trachomatis |
ES2788728T3 (es) | 2010-05-28 | 2020-10-22 | Spixia Biotechnology Ab | Antígeno de la MOMP quimérica, método y uso |
ES2900757T3 (es) | 2015-02-10 | 2022-03-18 | Ohio State Innovation Foundation | Plataformas de células B activadas por clamidia y procedimientos de las mismas |
CA3004924A1 (en) * | 2015-11-10 | 2017-05-18 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4271146A (en) * | 1979-09-06 | 1981-06-02 | Seawell Albert C | Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases |
-
1994
- 1994-11-02 CN CN 94193980 patent/CN1134112A/zh active Pending
- 1994-11-02 WO PCT/US1994/012626 patent/WO1995012411A1/en not_active Application Discontinuation
- 1994-11-02 BR BR9407986A patent/BR9407986A/pt not_active Application Discontinuation
- 1994-11-02 CA CA 2175081 patent/CA2175081A1/en not_active Abandoned
- 1994-11-02 AU AU11297/95A patent/AU701247B2/en not_active Ceased
- 1994-11-02 NZ NZ276874A patent/NZ276874A/en unknown
- 1994-11-02 EP EP95902425A patent/EP0726775A4/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
INFECTION AND IMMUNITY VOL 58 NO 9 1990 TAN ET AL PP3101-08 * |
Also Published As
Publication number | Publication date |
---|---|
WO1995012411A1 (en) | 1995-05-11 |
BR9407986A (pt) | 1996-12-03 |
CN1134112A (zh) | 1996-10-23 |
EP0726775A1 (en) | 1996-08-21 |
EP0726775A4 (en) | 1999-03-31 |
CA2175081A1 (en) | 1995-05-11 |
AU1129795A (en) | 1995-05-23 |
NZ276874A (en) | 1997-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Martinez et al. | Protection of goats against heartwater acquired by immunisation with inactivated elementary bodies of Cowdria ruminantium | |
CA1303988C (en) | Eimeria acervulina immunogens | |
JP5149242B2 (ja) | Invaplexワクチンを用いた免疫化により誘導される異種保護 | |
AU701247B2 (en) | Vaccine and method for treatment of chlamydial infections | |
Adamus et al. | Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp | |
Munir et al. | Outer membrane proteins of Brucella abortus vaccinal and field strains and their immune response in buffaloes | |
MISHIMA et al. | Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1 | |
Prescott et al. | Use of a virulence‐associated protein based enzyme‐linked immunosorbent assay for Rhodococcus equi serology in horses | |
Campos et al. | A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. | |
Fiske et al. | Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations | |
Champion et al. | Immunization with Treponema pallidum endoflagella alters the course of experimental rabbit syphilis | |
EP0283840A2 (en) | Mycoplasma hyopneumoniae antigen and uses therefor | |
AU2002314793A1 (en) | Heterologous protection induced by immunization with invaplex vaccine | |
Blanco et al. | The antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidum. | |
US5252328A (en) | Mycoplasma hyopneumoniae antigen and uses therefor | |
HELTING et al. | SEROTYPE DETERMINANT PROTEIN OF NEISSERIA MENINGITIDIS: Large Scale Preparation by Direct Detergent Treatment of the Bacterial Cells | |
Anacker et al. | Biological properties of rabbit antibodies to a surface antigen of Rickettsia rickettsii | |
AU2917892A (en) | Recombinant vaccine against lyme disease | |
US6790446B2 (en) | Campylobacter vaccine | |
PEREZ et al. | Characterization of variable immunodominant antigens of Cowdria ruminantium by ELISA and immunoblots | |
Nagy et al. | Iscom (Immunostimulating Complex) Vaccines Containing Mono‐or Polyvalent Pili of Enterotoxigenic E. coli; Immune Response of Rabbit and Swine | |
US9764017B2 (en) | Potomac horse fever isolates | |
RU2822516C1 (ru) | Новая вакцина против haemophilus parasuis | |
Saunders et al. | Humoral response of the mouse to Treponema pallidum. | |
Lukáčová et al. | Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |